Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association - PubMed (original) (raw)

Review

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

Tiffany M Powell-Wiley et al. Circulation. 2021.

Abstract

The global obesity epidemic is well established, with increases in obesity prevalence for most countries since the 1980s. Obesity contributes directly to incident cardiovascular risk factors, including dyslipidemia, type 2 diabetes, hypertension, and sleep disorders. Obesity also leads to the development of cardiovascular disease and cardiovascular disease mortality independently of other cardiovascular risk factors. More recent data highlight abdominal obesity, as determined by waist circumference, as a cardiovascular disease risk marker that is independent of body mass index. There have also been significant advances in imaging modalities for characterizing body composition, including visceral adiposity. Studies that quantify fat depots, including ectopic fat, support excess visceral adiposity as an independent indicator of poor cardiovascular outcomes. Lifestyle modification and subsequent weight loss improve both metabolic syndrome and associated systemic inflammation and endothelial dysfunction. However, clinical trials of medical weight loss have not demonstrated a reduction in coronary artery disease rates. In contrast, prospective studies comparing patients undergoing bariatric surgery with nonsurgical patients with obesity have shown reduced coronary artery disease risk with surgery. In this statement, we summarize the impact of obesity on the diagnosis, clinical management, and outcomes of atherosclerotic cardiovascular disease, heart failure, and arrhythmias, especially sudden cardiac death and atrial fibrillation. In particular, we examine the influence of obesity on noninvasive and invasive diagnostic procedures for coronary artery disease. Moreover, we review the impact of obesity on cardiac function and outcomes related to heart failure with reduced and preserved ejection fraction. Finally, we describe the effects of lifestyle and surgical weight loss interventions on outcomes related to coronary artery disease, heart failure, and atrial fibrillation.

Keywords: AHA Scientific Statements; atrial fibrillation; cardiovascular diseases; coronary artery disease; death, sudden; heart; heart failure; obesity.

PubMed Disclaimer

Figures

Figure 1.

Figure 1.. Pathophysiology of heart failure in obesity.

CVD indicates cardiovascular disease; and VLDL, very-low-density lipoprotein. Adapted from Rodriguez Flores et al with permission from Taylor & Francis Ltd (

https://www.tandfonline.com

). Copyright © 2017, Taylor & Francis Ltd.

Figure 2.

Figure 2.. Association between body mass index and risk of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF).

Reprinted from Pandey et al with permission from the American College of Cardiology Foundation. Copyright © 2018, American College of Cardiology Foundation.

Figure 3.

Figure 3.. Relationships between obesity and cardiac arrhythmias.

AF indicates atrial fibrillation.

Similar articles

Cited by

References

    1. Loos RJ. Genetic determinants of common obesity and their value in prediction. Best Pract Res Clin Endocrinol Metab. 2012;26:211–226. doi: 10.1016/j.beem.2011.11.003 - DOI - PubMed
    1. Gebreab SZ, Vandeleur CL, Rudaz D, Strippoli MF, Gholam-Rezaee M, Castelao E, Lasserre AM, Glaus J, Pistis G, Kuehner C, et al. Psychosocial stress over the lifespan, psychological factors, and cardiometabolic risk in the community. Psychosom Med. 2018;80:628–639. doi: 10.1097/PSY.0000000000000621 - DOI - PubMed
    1. Sommer I, Griebler U, Mahlknecht P, Thaler K, Bouskill K, Gartlehner G, Mendis S. Socioeconomic inequalities in non-communicable diseases and their risk factors: an overview of systematic reviews. BMC Public Health. 2015;15:914. doi: 10.1186/s12889-015-2227-y - DOI - PMC - PubMed
    1. Sallis JF, Glanz K. Physical activity and food environments: solutions to the obesity epidemic. Milbank Q. 2009;87:123–154. doi: 10.1111/j.1468-0009.2009.00550.x - DOI - PMC - PubMed
    1. Franks PW, McCarthy MI. Exposing the exposures responsible for type 2 diabetes and obesity. Science. 2016;354:69–73. doi: 10.1126/science.aaf5094 - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources